Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple ...
Our researchers talk to the Times Higher Education podcast about using AI to streamline dementia diagnosis and improve health equity for patients Sheffield Researchers, including Prof Heidi ...